The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Rationale for omega-3 fatty acids in heart disease

    Researchers from the University of South Dakota in Sioux Falls have reviewed the rationale for recommending long-chain omega-3 fatty acids  — eicosapentaenoic acid and docosahexaenoic acid (EPA and DHA) — in pill or fish form for general heart health.

    Here it is in case your forgot.

    • 6 epidemiological studies of EPA + DHA intake and the risk of coronary heart disease (CHD) death have been conducted in the US.
    • 5 studies reported significantly lower risk with higher intake.
    • A meta-analysis of the combined data from the studies showed significant risk reductions of 37% at an average EPA + DHA intake of 566 mg/day.

    The bottom line?
    US officials recommend that the target intake of long-chain omega-3 fatty acids is 400 to 500 mg/day of EPA + DHA.

    This can be achieved by eating 2 servings per week of oily fish (the current American Heart Association recommendation).

    11/3/08 20:55 JR

    Leave a Comment

    You must be logged in to post a comment.